# COVID-19 Convalescent Plasma

> **NCT04340050** · EARLY_PHASE1 · COMPLETED · sponsor: **University of Chicago** · enrollment: 10 (actual)

## Conditions studied

- Coronavirus

## Interventions

- **BIOLOGICAL:** anti-SARS-CoV-2 convalescent plasma

## Key facts

- **NCT ID:** NCT04340050
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-10
- **Primary completion:** 2020-12-23
- **Final completion:** 2020-12-23
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2024-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04340050

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04340050, "COVID-19 Convalescent Plasma". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04340050. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*